-
Innovation Ranking
Innovation Ranking - ChemoCentryx Inc
ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company's pipeline product includes Avacopan, CCX559,CCX587 and CCX507. Its Avacopan a lead candidate is an orally-administered complement inhibitor of the complement C5a receptor (C5aR), for the treatment of anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. ChemoCentryx also provide preclinical research for evaluating the effect of combination therapy with chemokine receptor and check point inhibitors. ChemoCentryx is headquartered...
-
Innovation Ranking
Innovation Ranking - Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that develops therapeutics in the area of male health and diagnostic products. It is developing a drug candidate for the treatment of Benign Prostatic Hyperplasia (BPH) and early-stage prostate cancer. The company markets diagnostic products for measuring tobacco product exposure and for the diagnosis of Alzheimer’s disease. Its diagnostic product portfolio includes N9icAlert test to determine smoking status; and TobacAlert home test to determine a person’s level of exposure to tobacco products,...
-
Innovation Ranking
Innovation Ranking - Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops novel medicines for rare and ultra-rare genetic diseases. It has four marketed products, Mepsevii (vestronidase alfa) for the treatment of Mucopolysaccharidosis (Sly syndrome); Dojolvi (triheptanoin), a highly purified, synthetic, 7-carbon fatty acid triglyceride for long-chain fatty acid oxidation disorders (LC-FAOD) and Crysvita (burosumab), a fully human monoclonal antibody for the treatment of X-linked hypophosphatemia (XLH); Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia (HoFH). Its pipeline includes DTX401 for...
-
Innovation Ranking
Innovation Ranking - Mayne Pharma Group Ltd
Mayne Pharma Group Ltd (Mayne Pharma) formerly HalcyGen Pharmaceuticals Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company offers products such as ASTRIX capsules, ERYC capsules, KAPANOL capsules, LOZANOC/TOLSURA capsules, AMETHIA tablets, AMIODARONE HCl tablets, AZURETTE tablets, BUDESONIDE capsules, CAMILA tablets and CLONIDINE transdermal patches among others. It also offers contract development and CDMO services such as pharmaceutical development, analytical testing and commercial manufacturing. The company operates manufacturing facilities in Australia and...
-
Innovation Ranking
Innovation Ranking - AnaptysBio Inc
AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody candidates for the treatment of atopic dermatitis, ovarian cancer, lung cancer, asthma, psoriasis, inflammation, and other autoimmune indications. The company develops its product candidates through its proprietary antibody discovery technology platform that is based on somatic hypermutation (SHM). The company has various product candidates under development for the treatment of moderate-to-severe adult atopic dermatitis, asthma, generalized pustular psoriasis and palmo-plantar pustular psoriasis, and human autoimmune...
-
Innovation Ranking
Innovation Ranking - Verastem Inc
Verastem Inc (Verastem) is a biopharmaceutical company. It carries out the discovery, development, and commercialization of novel small molecule drugs to treat cancer. The company’s most advanced product candidates include VS-6766, defactinib (VS-6063). Verastem products VS-6766 and defactinib (VS-6063), are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including, low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), colorectal cancer (CRC), pancreatic cancer, uveal melanoma, and endometrial cancer. The pipeline products focused...
-
Innovation Ranking
Innovation Ranking - Chinook Therapeutics Inc
Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. It's pipeline products include atrasentan, ADU-S100 for multiple tumors, CHK-336 for idiopathic hyperoxaluria among others. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sting pathway activators and B-select monoclonal antibodies to create immunotherapies for the treatment of cancers, infectious and autoimmune diseases. Its products are under development and are...
-
Innovation Ranking
Innovation Ranking - TherapeuticsMD Inc
TherapeuticsMD Inc (TherapeuticsMD) is an innovative pharmaceutical company. It develops products to address the unique changes and challenges women experience throughout the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The company's major products portfolio includes segesterone acetate and ethinyl estradiol, estradiol and progesterone capsules, prenatal vitamins, estradiol vaginal inserts. The company sells its products under the various brands name of VitamedMD, BocagreenMD, Annovera, Bijuva, vitaPearl, vitaTrue, vitaMedMD RediChew Rx, vitaMedMD...
-
Innovation Ranking
Innovation Ranking - MYOS RENS Technology Inc
MedAvail Holdings Inc (MedAvail Holdings), formerly MYOS RENS Technology Inc, is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken egg yolk that is processed using a patented technology which preserves its biological integrity and bioactivity for increase of muscle size and lean body mass in conjunction with resistance training. MYOS RENS’s biotherapeutics research and development activities are concentrated on...
-
Innovation Ranking
Innovation Ranking - Cellectar Biosciences Inc
Cellectar Biosciences Inc (Cellectar), is a biopharmaceutical company that discovers, develops and commercializes drugs for treatment of cancer. The company’s proprietary technology, phospholipid drug conjugates (PDC) delivery platform develops PDCs for the treatment and diagnosis of cancer. Its lead product includes CLR 131, is a small-molecule PDC, in Phase II clinical trials for the treatment of relapse or refractory multiple myeloma and B-cell lymphomas. The company is also evaluating CLR 131 in Phase I clinical trials for treatment of Pediatric...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.